Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease

Experimental Neurology

Volumn 213, Issue 1, 2008, Pages 137-144

  Wolf, Robert Christian ^a   Sambataro, Fabio ^b,c   Vasic, Nenad ^a   Schönfeldt Lecuona, Carlos ^a   Ecker, Daniel ^a   Landwehrmeyer, Bernhard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BARI   (Italy)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Functional magnetic resonance imaging; Independent component analysis; Premanifest Huntington's disease; Striatum; Working memory

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; MALE; MOTOR PERFORMANCE; MULTIVARIATE ANALYSIS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; SCORING SYSTEM; VERBAL MEMORY; WORKING MEMORY;

ADULT; AGE OF ONSET; BRAIN MAPPING; COGNITION DISORDERS; CORPUS STRIATUM; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; MUTATION; NERVE NET; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; NUCLEAR PROTEINS; PARIETAL LOBE; PREDICTIVE VALUE OF TESTS; PREFRONTAL CORTEX; PUTAMEN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 49349092621     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.05.017     Document Type: Article

References (54)

1. Backman L., Robins-Wahlin T.B., Lundin A., Ginovart N., and Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 120 (1997) 2207-2217
2. Bartels A., and Zeki S. The chronoarchitecture of the human brain-natural viewing conditions reveal a time-based anatomy of the brain. Neuroimage 22 (2004) 419-433
3. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
4. Behrens P.F., Franz P., Woodman B., Lindenberg K.S., and Landwehrmeyer G.B. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 125 (2002) 1908-1922
5. Bhide P.G., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A.B., Penney J., Golden J., Aronin N., and DiFiglia M. Expression of normal and mutant huntingtin in the developing brain. J. Neurosci. 16 (1996) 5523-5535
6. Calhoun V.D., Adali T., Pearlson G.D., and Pekar J.J. A method for making group inferences from functional MRI data using independent component analysis. Hum. Brain Mapp 14 (2001) 140-151
7. Calhoun V.D., Adali T., and Pekar J.J. A method for comparing group fMRI data using independent component analysis: application to visual, motor and visuomotor tasks. Magn. Reson. Imaging 22 (2004) 1181-1191
8. Celone K.A., Calhoun V.D., Dickerson B.C., Atri A., Chua E.F., Miller S.L., DePeau K., Rentz D.M., Selkoe D.J., Blacker D., Albert M.S., and Sperling R.A. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J. Neurosci. 26 (2006) 10222-10231
9. Ciarmiello A., Cannella M., Lastoria S., Simonelli M., Frati L., Rubinsztein D.C., and Squitieri F. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J. Nucl. Med. 47 (2006) 215-222
10. Correa N., Adali T., Yi-Ou L., and Calhoun V.D. Comparison of blind source separation algorithms for FMRI using a new Matlab toolbox: GIFT. Proc. IEEE Int Conf Acoustics, Speech, Signal Processing 5 (2005) 401-404
11. Damoiseaux, J.S., Beckmann, C.F., Sanz Arigita, E.J., Barkhof, F., Scheltens, Ph., Stam, C.J., Smith, S.M., Rombouts S.A.R.B., in press. Reduced resting-state brain activity in the "default network" in normal aging. Cereb. Cortex. doi:10.1093/cercor/bhm207.
12. D'Esposito M., Postle B.R., and Rypma B. Prefrontal cortical contributions to working memory: evidence from event-related fMRI studies. Exp. Brain Res. 133 (2000) 3-11
13. DiProspero N.A., Chen E.Y., Charles V., Plomann M., Kordower J.H., and Tagle D.A. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J. Neurocytol. 33 (2004) 517-533
14. Duvernoy H.M. The Human Brain (1999), Wien, New York, Springer
15. Feigin A., Leenders K.L., Moeller J.R., Missimer J., Kuenig G., Spetsieris P., Antonini A., and Eidelberg D. Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J. Nucl. Med. 42 (2001) 1591-1595
16. Feigin A.S., Ghilardi M.F., Huang C., Yilong M., Carbon M., Guttman M., Paulsen J.S., Ghez C.P., and Eidelberg D. Preclinical Huntington's disease: compensatory brain responses during learning. Ann. Neurol. 59 (2006) 53-59
17. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., MacDonald M.E., Beal M.F., and Hersch S.M. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17 (1997) 3052-3063
18. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., and Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of cluster-size threshold. Magn. Reson. Med. 33 (1995) 636-647
19. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15 (2002) 870-878
20. Gomez-Anson B., Alegret M., Munoz E., Sainz A., Monte G.C., and Tolosa E. Decreased frontal choline and neuropsychological performance in preclinical Huntington disease. Neurology 68 (2007) 906-910
21. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., and Li X.J. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19 (1999) 2522-2534
22. Hassel, B., Tessler, S., Faull, R.M., Emson, P.C., 2007. Glutamate uptake is reduced in prefrontal cortex in Huntington's Disease. Neurochem Res published online. DOI 10.1007/s11064-11007-19463-11061.
23. Hickey M.A., and Chesselet M.F. The use of transgenic and knock-out mice to study Huntington's disease. Cytogenet. Genome Res. 100 (2003) 276-286
24. Huntington-Study-Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Movement Disorders 11 (1996) 136-142
25. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., and McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Journal Neurol Neurosurg and Psychiatry 76 (2007) 650-655
26. Laforet G.A., Sapp E., Chase K., McIntyre C., Boyce F.M., Campbell M., Cadigan B.A., Warzecki L., Tagle D.A., Reddy P.H., Cepeda C., Calvert C.R., Jokel E.S., Klapstein G.J., Ariano M.A., Levine M.S., DiFiglia M., and Aronin N. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J. Neurosci. 21 (2001) 9112-9123
27. Lancaster J.L., Tordesillas-Gutierrez D., Martinez M., Salinas F., Evans A., Zilles K., Mazziotta J.C., and Fox P.T. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum. Brain Mapp. 28 (2007) 1194-1205
28. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R., and Group I.H.s.D.C. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 65 (2004) 267-277
29. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., Robbins T.W., and Sahakian B.J. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121 Pt 7 (1998) 1329-1341
30. Li Y.O., Adali T., and Calhoun V.D. Estimating the number of independent components for functional magnetic resonance imaging data. Human Brain Mapping 28 (2007) 1251-1266
31. Middleton F.A., and Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Research Reviews 31 (2000) 236-250
32. Montoya A., Price B.H., Menear M., and Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J. Psychiatry Neurosci. 31 (2006) 21-29
33. Nehl C., Ready R.E., Hamilton J., and Paulsen J.S. Effects of depression on working memory in presymptomatic Huntington's disease. J. Neuropsychiatry Clin. Neurosci. 13 (2001) 342-346
34. Nopoulos P., Magnotta V., Mikos A., Paulson H., Andreasen N.C., and Paulsen J.S. Morphology of the cerebral cortex in preclinical Huntington's disease. American Journal of Psychiatry 164 (2007) 1428-1429
35. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
36. Owen A.M., McMillan K.M., Laird A.R., and Bullmore E. N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum. Brain Mapp. 25 (2005) 46-59
37. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., and Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 59 (2006) 57-63
38. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., Reynolds N.C., and Rao S.M. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. AJNR 25 (2004) 1715-1721
39. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E., Brandt J., Bassett S.S., and Ross C.A. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 55 (2004) 879-883
40. Reading S.A., Yassa M.A., Bakker A., Dziorny A.C., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R., Aylward E., Brandt J., Mori S., van Zijl P.C., Bassett S.S., and Ross C.A. Regional white matter change in pre-symptomatic Huntington's disease: a diffusion tensor imaging study. Psychiatry Res. Neuroimaging 140 (2005)
41. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., and Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 65 (2005) 745-747
42. Rosas H.D., Tuch D.S., Hevelone N.D., Zaleta A.K., Vangel M., Hersch S.M., and Salat D.H. Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov. Disord. 21 (2006) 1317-1325
43. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., and DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42 (1997) 604-612
44. Solomon A.C., Stout J.C., Johnson S.A., Langbehn D.R., Aylward E.H., Brandt J., Ross C.A., Beglinger L., Hayden M.R., Kieburtz K., Kayson E., Julian-Baros E., Duff K., Guttman M., Nance M., Oakes D., Shoulson I., Penziner E., and Paulsen J.S. Verbal episodic memory declines prior to diagnosis in Huntington's disease. Neuropsychologia 45 (2007) 1767-1776
45. Sternberg S. High-speed scanning in human memory. Science 153 (1966) 652-654
46. Stevens M.C., Kiehl K.A., Pearlson G.D., and Calhoun V.D. Brain network dynamics during error commission. Hum. Brain Mapp. (2007)
47. Talairach J., and Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain (1988), Thieme Medical Publishers, New York, NY
48. Thiruvady D.R., Georgiou-Karistianis N., Egan G.F., Ray S., Sritharan A., Farrow M., Churchyard A., Chua P., Bradshaw J.L., Brawn T.-L., and Cunnington R. Functional connectivity of the prefrontal cortex in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry 78 (2007) 127-133
49. Vonsattel J.P., Myers R.H., and Stevens T.J. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577
50. Ward J., Sheppard J.M., Shpritz B., Margolis R.L., Rosenblatt A., and Brandt J. A four-year prospective study of cognitive functioning in Huntington's disease. J. Int. Neuropsychol. Soc. 12 (2006) 445-454
51. Wolf R.C., Vasic N., Schönfeldt-Lecuona C., Ecker D., and Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Human Brain Mapping (2008) 10.1002/hbm.20502 published online Jan 2
52. Wolf R.C., Vasic N., Schönfeldt-Lecuona C.L., Landwehrmeyer G.B., and Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 130 (2007) 2845-2857
53. Wolf R.C., and Walter H. Evaluation of a novel event-related parametric fMRI paradigm investigating prefrontal function. Psychiatry Res. Neuroimaging 140 (2005) 73-83
54. Zimbelman J.L., Paulsen J.S., Mikos A.E., Reynolds N.C., Hoffman R.G., and Rao S.M. fMRI detection of early neural dysfunction in preclinical Huntington's disease. Journal of the International Neuropsychological Society 13 (2007) 758-769